TrialHarm reduction journal2024

Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.

Mehri S McKellar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.